Adamas Pharmaceuticals
ADMS
$8.22
Share price
0.00%
Change (1 day)
16,340.00%
Change (1 year)
Categories
Market capitalization of Adamas Pharmaceuticals (ADMS)
Market cap: $0.37 Billion
As of May 2024 Adamas Pharmaceuticals has a market cap of $0.37 Billion. This makes Adamas Pharmaceuticals the world's 6327th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Adamas Pharmaceuticals from 2014 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.37 B | 0% |
| 2021 | $0.37 B | 204.77% |
| 2020 | $0.12 B | 16.52% |
| 2019 | $0.10 B | -54.76% |
| 2018 | $0.23 B | -69.65% |
| 2017 | $0.77 B | 107.8% |
| 2016 | $0.37 B | -29.11% |
| 2015 | $0.52 B | 71.9% |
| 2014 | $0.30 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 AbbVie ABBV | $283.24 B | 75,157.37% | 🇺🇸 USA |
 Merck MRK | $329.84 B | 87,539.44% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $91.89 B | 24,315.27% | 🇬🇧 UK |
 Zogenix ZGNX | $1.50 B | 298.59% | 🇺🇸 USA |
 Supernus Pharmaceuticals
SUPN | $1.72 B | 357.33% | 🇺🇸 USA |